Sarah W. Gordon, DO
Associate Professor
Medical Director, Bodine Infusion
Clinical Co-Director of Phase 1 Program/Early Drug Development Office, Sidney Kimmel Comprehensive Cancer Center
Lung Program Leader, Enterprise Jefferson Health
Contact
Sarah W. Gordon, DO
Associate Professor
Medical Director, Bodine Infusion
Clinical Co-Director of Phase 1 Program/Early Drug Development Office, Sidney Kimmel Comprehensive Cancer Center
Lung Program Leader, Enterprise Jefferson Health
Education
Medical School
Philadelphia College of Osteopathic Medicine
Residency
Drexel University College of Medicine, Hahnemann University Hospital
Fellowship
Hematology/Oncology Fellowship, Virginia Commonwealth University
Most Recent Peer-Reviewed Publications
- A phase 1 study of regorafenib and sildenafil in adults with advanced solid tumors
- A Phase II Basket Trial of Dual Anti–CTLA-4 and Anti–PD-1 Blockade in Rare Tumors (DART SWOG 1609 Cohort 47) in Patients with Gestational Trophoblastic Neoplasia
- Case report: paradoxically reversible perfusion defects on vasodilator stress imaging in a case of metastatic coronary compression
- Post hoc analyses of GOG 9923: Does BRCA status affect toxicities?: An NRG oncology study
- A phase I study of intravenous or intraperitoneal platinum based chemotherapy in combination with veliparib and bevacizumab in newly diagnosed ovarian, primary peritoneal and fallopian tube cancer
Certifications
- Internal Medicine
- Internal Medicine, Hematology
- Internal Medicine, Oncology